{"id":"https://openalex.org/W2472019910","doi":"https://doi.org/10.1038/onc.2016.216","title":"FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling","display_name":"FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling","alternate_titles":[],"publication_year":2016,"publication_date":"2016-06-27","ids":{"openalex":"https://openalex.org/W2472019910","doi":"https://doi.org/10.1038/onc.2016.216","mag":"2472019910","pmid":"https://pubmed.ncbi.nlm.nih.gov/27345413","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5290037"},"language":"en","primary_location":{"id":"doi:10.1038/onc.2016.216","doi":"https://doi.org/10.1038/onc.2016.216","is_oa":true,"landing_page_url":"https://doi.org/10.1038/onc.2016.216","pdf_url":"https://www.nature.com/articles/onc2016216.pdf","source":{"id":"https://openalex.org/S128439998","display_name":"Oncogene","issn_l":"0950-9232","issn":["0950-9232","1476-5594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2472019910"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/onc2016216.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029586728","display_name":"Christopher Daly","orcid":"https://orcid.org/0000-0003-3800-8174","observed_orcids":["https://orcid.org/0000-0003-3800-8174"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"C Daly","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078906917","display_name":"Carla Castanaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Castanaro","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W Zhang","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019818762","display_name":"Q Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Q Zhang","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103044736","display_name":"Yunna Wei","orcid":"https://orcid.org/0009-0003-7773-5494","observed_orcids":["https://orcid.org/0009-0003-7773-5494"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y Wei","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084150047","display_name":"Min Ni","orcid":"https://orcid.org/0000-0001-6382-0848","observed_orcids":["https://orcid.org/0000-0001-6382-0848"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Ni","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055898350","display_name":"Tara M. Young","orcid":"https://orcid.org/0000-0001-9677-3494","observed_orcids":["https://orcid.org/0000-0001-9677-3494"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T M Young","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067057749","display_name":"Lance Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Zhang","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103068048","display_name":"Elena Burova","orcid":"https://orcid.org/0000-0002-5843-4093","observed_orcids":["https://orcid.org/0000-0002-5843-4093"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E Burova","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015053419","display_name":"Gavin Thurston","orcid":"https://orcid.org/0000-0002-4105-5919","observed_orcids":["https://orcid.org/0000-0002-4105-5919"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Thurston","raw_affiliation_strings":["Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA","institution_ids":["https://openalex.org/I186523950"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029586728"],"corresponding_institution_ids":["https://openalex.org/I186523950"],"apc_list":{"value":5990,"currency":"USD","value_usd":5990},"apc_paid":{"value":5990,"currency":"USD","value_usd":5990},"fwci":4.0006,"has_fulltext":true,"cited_by_count":61,"citation_normalized_percentile":{"value":0.95404969,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"36","issue":"4","first_page":"471","last_page":"481"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6166999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6166999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.334199994802475,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12287","display_name":"Fibroblast Growth Factor Research","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fgfr3-tacc3-fusion","display_name":"FGFR3-TACC3 fusion","score":0.9290000200271606},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8399999737739563},{"id":"https://openalex.org/keywords/egfr-inhibition","display_name":"EGFR inhibition","score":0.8579999804496765},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9589999914169312},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.8569999933242798},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ras-erk-pathway","display_name":"Ras/ERK pathway","score":0.7009999752044678},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9259999990463257},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9440000057220459},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.8138134479522705},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6831769943237305},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.6251746416091919},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6245883107185364},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.6182696223258972},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5032901167869568},{"id":"https://openalex.org/C116227048","wikidata":"https://www.wikidata.org/wiki/Q18021243","display_name":"Cyclin-dependent kinase 8","level":4,"score":0.48898446559906006},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.4809126555919647},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4533764719963074},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4371534585952759},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.42645758390426636},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29789823293685913},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.22018930315971375},{"id":"https://openalex.org/C161879069","wikidata":"https://www.wikidata.org/wiki/Q904082","display_name":"Notch signaling pathway","level":3,"score":0.12054631114006042},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10468003153800964},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07538306713104248},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077195","descriptor_name":"Squamous Cell Carcinoma of Head and Neck","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002294","descriptor_name":"Carcinoma, Squamous Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006258","descriptor_name":"Head and Neck Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008869","descriptor_name":"Microtubule-Associated Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008869","descriptor_name":"Microtubule-Associated Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014162","descriptor_name":"Transfection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015514","descriptor_name":"Oncogene Proteins, Fusion","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015514","descriptor_name":"Oncogene Proteins, Fusion","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051498","descriptor_name":"Receptor, Fibroblast Growth Factor, Type 3","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051498","descriptor_name":"Receptor, Fibroblast Growth Factor, Type 3","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/onc.2016.216","doi":"https://doi.org/10.1038/onc.2016.216","is_oa":true,"landing_page_url":"https://doi.org/10.1038/onc.2016.216","pdf_url":"https://www.nature.com/articles/onc2016216.pdf","source":{"id":"https://openalex.org/S128439998","display_name":"Oncogene","issn_l":"0950-9232","issn":["0950-9232","1476-5594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5290037","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5290037/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"Text"},{"id":"pmid:27345413","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27345413","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/onc.2016.216","doi":"https://doi.org/10.1038/onc.2016.216","is_oa":true,"landing_page_url":"https://doi.org/10.1038/onc.2016.216","pdf_url":"https://www.nature.com/articles/onc2016216.pdf","source":{"id":"https://openalex.org/S128439998","display_name":"Oncogene","issn_l":"0950-9232","issn":["0950-9232","1476-5594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncogene","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2472019910.pdf","grobid_xml":"https://content.openalex.org/works/W2472019910.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1960850967","https://openalex.org/W1966455897","https://openalex.org/W1967279935","https://openalex.org/W1967394241","https://openalex.org/W1969391810","https://openalex.org/W1972947623","https://openalex.org/W1973260880","https://openalex.org/W1979056373","https://openalex.org/W1985585626","https://openalex.org/W1986241711","https://openalex.org/W1994075309","https://openalex.org/W2002714006","https://openalex.org/W2004893350","https://openalex.org/W2005036868","https://openalex.org/W2007223616","https://openalex.org/W2008550171","https://openalex.org/W2020047273","https://openalex.org/W2024896457","https://openalex.org/W2037690883","https://openalex.org/W2039705224","https://openalex.org/W2042103473","https://openalex.org/W2052705131","https://openalex.org/W2053343049","https://openalex.org/W2069526613","https://openalex.org/W2081069777","https://openalex.org/W2085690948","https://openalex.org/W2096362504","https://openalex.org/W2096869304","https://openalex.org/W2101106357","https://openalex.org/W2107977954","https://openalex.org/W2108246579","https://openalex.org/W2110933411","https://openalex.org/W2113235293","https://openalex.org/W2114200265","https://openalex.org/W2115790682","https://openalex.org/W2119746400","https://openalex.org/W2127990562","https://openalex.org/W2132394486","https://openalex.org/W2142564546","https://openalex.org/W2154469201","https://openalex.org/W2155384808","https://openalex.org/W2158819778","https://openalex.org/W2159639650","https://openalex.org/W2160574552","https://openalex.org/W2161821474","https://openalex.org/W2165267819","https://openalex.org/W2263837770","https://openalex.org/W2409420104"],"related_works":["https://openalex.org/W2734669213","https://openalex.org/W3207831837","https://openalex.org/W3081505725","https://openalex.org/W4225164821","https://openalex.org/W2023344600","https://openalex.org/W3159430777","https://openalex.org/W1994075309","https://openalex.org/W2964880501","https://openalex.org/W3013971701"],"abstract_inverted_index":{"The":[0],"epidermal":[1],"growth":[2],"factor":[3],"receptor":[4],"(EGFR)":[5],"is":[6],"a":[7,185],"clinically":[8],"validated":[9,77],"target":[10],"in":[11,98,148,163,191],"head":[12],"and":[13,51,130],"neck":[14],"squamous":[15],"cell":[16,100,133,151,196],"carcinoma":[17],"(HNSCC),":[18],"where":[19],"EGFR-blocking":[20],"antibodies":[21],"are":[22,139,172],"approved":[23],"for":[24,112,143,176],"first-line":[25],"treatment.":[26],"However,":[27],"as":[28,78,158],"with":[29],"other":[30],"targeted":[31],"therapies,":[32],"intrinsic/acquired":[33],"resistance":[34,108,125,162,190],"mechanisms":[35],"limit":[36],"efficacy.":[37],"In":[38],"the":[39,59,81],"FaDu":[40],"HNSCC":[41,129,150],"xenograft":[42],"model,":[43],"we":[44],"show":[45],"that":[46,68,103,169],"combined":[47],"blockade":[48],"of":[49,62,80,90,96,126,145,154,161,174,188,194],"EGFR":[50,136,177],"ERBB3":[52],"promotes":[53],"rapid":[54],"tumor":[55],"regression,":[56],"followed":[57],"by":[58,84,109],"eventual":[60],"outgrowth":[61],"resistant":[63,69,82,99],"cells.":[64],"RNA":[65],"sequencing":[66],"revealed":[67],"cells":[70],"express":[71],"FGFR3-TACC3":[72,91,104,121,155,180],"fusion":[73,92,105,122,156,181],"proteins,":[74],"which":[75],"were":[76],"drivers":[79,160],"phenotype":[83],"several":[85],"approaches,":[86],"including":[87],"CRISPR-mediated":[88],"inactivation":[89],"genes.":[93],"Interestingly,":[94],"analysis":[95],"signaling":[97,114,147],"lines":[101,134],"demonstrated":[102],"proteins":[106,123,157,182],"promote":[107,124],"preferentially":[110],"substituting":[111,175],"EGFR/RAS/ERK":[113],"rather":[115],"than":[116],"ERBB3/PI3K/AKT":[117],"signaling.":[118,178],"Furthermore,":[119],"although":[120],"additional":[127],"EGFR-dependent":[128,192],"lung":[131],"cancer":[132],"to":[135,141],"blockade,":[137],"they":[138],"unable":[140],"compensate":[142],"inhibition":[144],"PI3K":[146],"PIK3CA-mutant":[149],"lines.":[152],"Validation":[153],"endogenous":[159],"our":[164],"screen":[165],"provides":[166],"strong":[167],"evidence":[168],"these":[170],"fusions":[171],"capable":[173],"Thus,":[179],"may":[183],"represent":[184],"novel":[186],"mechanism":[187],"acquired":[189],"cancers":[193],"multiple":[195],"lineages.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2472019910","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-07-22T00:00:00"}
